SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2882From scientist perspective... contagionlive.com Can We Beat SARS-CoV-2? LessonMiljenko Zuanic-3/28/2020
2881Abs binding to the distant epitope is not as potent as one binding to epitope onMiljenko Zuanic-3/27/2020
2880"Cross reactivity (SARS/MERS) for ACE2/RBD binding assay was not observed, CuttingEdge Bio-3/27/2020
2879OT:VIR (and relevant to REGN) My point is that they went after sera-Abs from recMiljenko Zuanic-3/27/2020
2878siRNA target mRNA gene from viral-RNA. siRNA need to penetrate cells in lung/resMiljenko Zuanic-3/27/2020
2877Prophylaxis will not work for any Abs if there is no distribution/penetration inMiljenko Zuanic-3/27/2020
2876Well I credit them for trying, but they are rather "new" and so I'CuttingEdge Bio-3/27/2020
2875Well, neither of my comments were sarcastic. This is from the full text of marmCuttingEdge Bio-3/27/2020
2874I thought the whole point of the antibody was to deliver the siRNA to the targetFelix B-3/26/2020
2873I am not talking about siRNA. I am talking about Abs isolated from pts recoveredMiljenko Zuanic-3/26/2020
2872Surprised by they (ANLY) parter with REGN given their current colab and their (RFelix B13/26/2020
2871Note that vir is partnering with alny Going by the agreement, the companies wilBiotechwantabe-3/26/2020
2870Of topic: VIR What do You think about Vir efforts and capability on this field (Miljenko Zuanic-3/26/2020
2869< Did you read the full text? Save your accusations.> No, I did not! :-( Miljenko Zuanic-3/26/2020
2868It's not sarcasm, they mentioned nebulizer delivery as a potential solution CuttingEdge Bio-3/26/2020
2867Is that possibility? Before bringing *sarcasm* to the field, let evaluate FACTS Miljenko Zuanic-3/26/2020
2866So are they planning to treat with a nebulizer formulation? This paper's rCuttingEdge Bio-3/26/2020
2865<This was a ph1 in healthy volunteers, so what was there to report?. How abouMiljenko Zuanic-3/23/2020
2864This is interesting and in stark contrast to the mouse infection study. It woulCuttingEdge Bio-3/22/2020
2863This was a ph1 in healthy volunteers, so what was there to report?CuttingEdge Bio-3/22/2020
2862"My point is my concern that just binding to pipe/envelope-proteins on *unaCuttingEdge Bio-3/22/2020
2861Treatment failure (MERS-CoV) in animal model! ncbi.nlm.nih.govMiljenko Zuanic-3/22/2020
2860Why they (REGN) did not reported data from MRS-CoV, P1? clinicaltrials.govMiljenko Zuanic-3/22/2020
2859Geia, researchgate.net It’s half Greece to me. Probably need to be a geneous Biotechwantabe-3/22/2020
2858<I'm not sure what point you're trying to make from the Cell paper.&gMiljenko Zuanic-3/22/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News